Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
暂无分享,去创建一个
M. Phipps | K. Bibbins-Domingo | D. Grossman | C. Mangione | D. Owens | D. Harper | A. Kemper | M. Gillman | A. Krist | K. Davidson | M. Pignone | J. Epling | W. Phillips | S. Curry | A. Kurth | C. Landefeld | Francisco A. R. García | A. Siu | Diane M. Harper | Matthew W. Gillman | Carol M. Mangione | Michael P. Pignone | Karina W. Davidson | Kirsten Bibbins-Domingo | David C. Grossman | Susan J. Curry | Alex R. Kemper | Ann E. Kurth | William R. Phillips | Maureen G. Phipps | Douglas K. Owens | Albert Siu
[1] C. Flowers,et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.
[2] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[3] Joseph A Hill. United States Life Tables , 2013 .
[4] Jennifer S Lin,et al. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.
[5] A. Zauber,et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state‐of‐the‐science review , 2016, Cancer.
[6] Eric J Feuer,et al. Secular trends in colon and rectal cancer relative survival. , 2013, Journal of the National Cancer Institute.
[7] S. Hendren,et al. Colorectal cancer outcomes and treatment patterns in patients too young for average‐risk screening , 2016, Cancer.
[8] G. Cooper,et al. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries , 2004, Cancer.
[9] B. Larsen. [Colorectal cancer screening]. , 2010, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[10] D. Ahlquist,et al. Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People. , 2016, Mayo Clinic proceedings.
[11] A. Jemal,et al. Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[12] Á. Lanas,et al. Vorsorge des kolorektalen Karzinoms: Koloskopie oder immunologischer Stuhltest , 2013, Zeitschrift für Gastroenterologie.
[13] Reiko Nishihara,et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. , 2013, The New England journal of medicine.
[14] Á. Lanas,et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. , 2012, The New England journal of medicine.
[15] T. Wilt,et al. Screening for cancer: advice for high-value care from the American College of Physicians. , 2015, Annals of internal medicine.
[16] O. Dominic,et al. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009, The American Journal of Gastroenterology.
[17] Ruth Etzioni,et al. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. , 2014, Annals of internal medicine.
[18] R. Nelson,et al. Colorectal , 1994, Current opinion in general surgery.
[19] D. Wickerham,et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. , 1999, Journal of the National Cancer Institute.
[20] S. Chiou,et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program , 2015, Cancer.
[21] M. Hernán,et al. The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer , 2012, Endoscopy.
[22] J. Faivre,et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. , 2004, Gastroenterology.
[23] C. Klabunde,et al. Vital Signs: Colorectal Cancer Screening Test Use — United States, 2012 , 2013, MMWR. Morbidity and mortality weekly report.
[24] O. Kronborg,et al. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds , 2004, Scandinavian journal of gastroenterology.
[25] Karen M Kuntz,et al. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. , 2016, JAMA.
[26] J. Willis,et al. Performance of multitarget stool DNA testing in African American patients , 2018, Cancer.
[27] M. Tonelli,et al. Recommendations on screening for colorectal cancer in primary care , 2016, Canadian Medical Association Journal.
[28] Douglas K Rex,et al. Corrigendum: American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009, The American Journal of Gastroenterology.
[29] Philip S Rosenberg,et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013 , 2017, Journal of the National Cancer Institute.
[30] Elizabeth M Webber,et al. Family history and the natural history of colorectal cancer: systematic review , 2015, Genetics in Medicine.
[31] David Lieberman,et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. , 2017, Gastroenterology.
[32] M. Bretthauer,et al. Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years , 2016, Annals of Internal Medicine.
[33] M. Hernán,et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. , 2014, JAMA.
[34] W. Baine,et al. The Agency for Healthcare Research and Quality , 2006, Italian Journal of Public Health.
[35] B. Levin,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.
[36] C M Mangham,et al. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up , 2011, Gut.
[37] Angela Fagerlin,et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. , 2012, Archives of internal medicine.
[38] O. Brawley. Colorectal cancer control: providing adequate care to those who need it. , 2014, Journal of the National Cancer Institute.
[39] D. Ransohoff,et al. Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.
[40] B. Levin,et al. Colorectal cancer screening. Clinical practice guidelines in oncology. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.
[41] Chyke A Doubeni,et al. Racial Disparities in Colorectal Cancer Survival: Is Elimination of Variation in Care the Cure? , 2015, Journal of the National Cancer Institute.
[42] L. Seeff,et al. Patterns of Colorectal Cancer Test Use, Including CT Colonography, in the 2010 National Health Interview Survey , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[43] Thomas Rösch,et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer , 2013, Gut.
[44] Kirsten Bibbins-Domingo,et al. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. , 2016, Annals of internal medicine.
[45] Bernadette Mazurek Melnyk,et al. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.